27 Oct 2025
In a sponsored article for STAT News, Labcorp’s Vice President of Science and Technology Development, Bob Daber, outlines how variant interpretation — not just sequencing — is the pivotal step in delivering meaningful results for rare disease patients. The piece highlights the story of young Rowan, whose diagnosis of neonatal-onset epileptic encephalopathy hinged on interpreting two variants in the SLC13A5 gene.
With over 12 million genetic tests and 45 billion laboratory results, Labcorp deploys proprietary AI tools like Moon™ and knowledge-bases like Apollo™ to interpret variants in minutes, and has already submitted more than 1.7 million classifications to the public ClinVar database.
Daber emphasizes how linking diagnostics to therapies and trials can change patient trajectories — and invites readers to understand Labcorp’s role in scaling this critical work. Read the full article on STAT News to learn more.